By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Atara Biotherapeutics 

2659 Townsgate Road
Suite 236
Thousand Oaks  California  91361  U.S.A.
Phone: 805-309-0888 Fax: n/a



Company News
Atara Biotherapeutics (ATRA)' Collaborating Investigators To Present Clinical Data On T-Cell Therapy For EBV Lymphoma At A Clinical Trials Plenary Session At The American Association for Cancer Research Annual Meeting 2015 3/19/2015 7:59:59 AM
Atara Biotherapeutics (ATRA) Names David A. Carmel As Head Of Immunotherapy 3/3/2015 7:49:27 AM
Atara Biotherapeutics (ATRA) Release: FDA Grants Breakthrough Therapy Designation To Epstein-Barr Virus (EBV) Targeted T-Cells For Treatment Of EBV- Associated Lymphoproliferative Disease 3/2/2015 10:53:56 AM
Atara Biotherapeutics (ATRA) Announces Closing Of Underwritten Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 2/19/2015 7:49:53 AM
Atara Biotherapeutics (ATRA) Announces Pricing Of Its $65.5 Million Offering Of Common Stock 2/12/2015 7:28:19 AM
Atara Biotherapeutics (ATRA) Announces Proposed Offering Of Common Stock 2/10/2015 7:43:46 AM
Atara Biotherapeutics (ATRA) To Present At The J.P. Morgan Healthcare Conference 1/9/2015 8:15:27 AM
Atara Biotherapeutics (ATRA) Announces Third Quarter 2014 Operating Results 11/12/2014 8:00:26 AM
Atara Biotherapeutics (ATRA)' Collaborating Investigators To Present Data At The American Society of Hematology Annual Meeting 2014 11/6/2014 10:36:41 AM
Atara Biotherapeutics (ATRA) Doses First Patient In Phase 1 Clinical Study Of STM 434, An Activin Inhibitor 10/22/2014 7:15:43 AM